1-TEST CYP is an injectable steroid that contains 100mg of Dihydroboldenone Cypionate.
Dihydroboldenone, also referred to as 1-Testosterone Cypionate, is a 5-alpha reduced variant of the steroid boldenone. The absence of 5-alpha reduction in this compound allows users to take it without experiencing the adverse side effects typically linked to Dihydroboldenone Cypionate's chemical reaction, but it also means the benefits are diminished. In fact, 1-TEST CYP is chemically identical to Methenolone (Prima 100) except for the 1-methylation found in Methenolone. Additionally, 1-TEST CYP shares structural similarities with Bold 200 and is less similar to 1-TEST CYP itself, despite its commonly used designation as 1-Testosterone Cypionate.
Consequently, some female athletes might consider using 1-TEST CYP as well. Although there is still the possibility of developing virilization symptoms, they tend to be less severe compared to synthetic testosterone steroids or other more potent substances. However, this does not imply that 1-TEST CYP is a mild drug. This discussion clarifies the nature of the drug, helping to illustrate the effects of 1-TEST CYP, both beneficial and adverse.
While 1-TEST CYP is not excessively androgenic, it is a strong anabolic agent. Research has indicated that this drug binds exceptionally well and selectively to androgen receptors, promoting the transactivation of androgen receptor-dependent reporter genes. This characteristic translates to a drug capable of inducing substantial muscle growth without causing androgenic side effects. 1-TEST CYP has proven to be significantly more anabolic than various compounds and even testosterone steroids themselves. This aspect is particularly advantageous for many athletes and bodybuilders.
1-TEST CYP Usage:
In terms of duration of use, due to the drug's mild nature, prolonged use of 1-TEST CYP can generally be sustained with minimal serious complications. There are no significant concerns regarding hepatotoxicity or severe kidney strain, and its impact on other critical health markers, such as blood pressure, is relatively mild for most users.
Regarding specific dosages, the lower range is typically considered to be 300-400 mg per week for male users. As with all drugs, this figure can vary individually and depends on how significant an effect the user hopes to achieve with 1-TEST CYP. For higher, effective doses, this also varies based on several factors. Doses around one gram per week are common for some users, while others may attempt higher amounts. Ultimately, it comes down to how much one is willing to use and at which point the benefits of increasing the dose might be compromised by the negatives.
For females, the standard guidelines for 1-TEST CYP are consistent with those for other substances. If side effects become too intense, the drug can be discontinued immediately, and low doses should be initiated at the start of the cycle, with the possibility of increasing once the user's tolerance is assessed. A starting point of 25 to 100 mg per week would be reasonable for most female users with little to moderate experience with anabolic steroids.